Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS
- 1 August 1996
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology
- Vol. 47 (2) , 583-585
- https://doi.org/10.1212/wnl.47.2.583
Abstract
We report a 36-year-old man with MELAS in whom a 5-month course of high-dose oral idebenone, a derivative of coenzyme Q10, increased markedly cerebral metabolic ratio of oxygen and oxygen extraction fraction without increased cerebral blood flow with PET. The results indicate that idebenone improves mitochondrial oxidative metabolism in the brain and suggest a therapeutic potential of idebenone for MELAS. NEUROLOGY 1996;47: 583-585Keywords
This publication has 2 references indexed in Scilit:
- PrefaceActa Neurologica Scandinavica, 1991
- THE EPIDEMIOLOGY OF MULTIPLE SCLEROSIS IN THREE AUSTRALIAN CITIES: PERTH, NEWCASTLE AND HOBARTBrain, 1988